Indication

Pseudomonas aeruginosa joint infection

A *Pseudomonas aeruginosa* joint infection is a severe, destructive form of septic arthritis or periprosthetic joint infection caused by the opportunistic Gram-negative bacillus *Pseudomonas aeruginosa*. Read more about Pseudomonas aeruginosa joint infection

115 drugs 71 manufacturers

Advertisement

Drugs that treat it

Common Pseudomonas aeruginosa joint infection therapies.

Showing 100–108 of 115 drugs

AMIKACIN SULFATE

AMINOGLYCOSIDES, PARENTERAL·STAPHYLOCOCCAL SEPTICEMIA·+60
Avet Pharmaceuticals
Filter & compare in the drug finder →Opens the drug finder with Pseudomonas aeruginosa joint infection preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Pseudomonas aeruginosa joint infection.

A *Pseudomonas aeruginosa* joint infection is a severe, destructive form of septic arthritis or periprosthetic joint infection caused by the opportunistic Gram-negative bacillus *Pseudomonas aeruginosa*.

It primarily affects the musculoskeletal system, most frequently presenting in individuals with prosthetic implants, persons who inject drugs, immunocompromised hosts, or patients who have experienced direct penetrating joint trauma, invasive orthopedic procedures, or bacteremic seeding.

The condition is characterized clinically by localized joint pain, swelling, erythema, and marked loss of motion, alongside systemic signs of inflammation.

Pathophysiologically, the organism's intense inflammatory induction, tissue-destructive virulence factors, and robust capacity for biofilm formation drive rapid articular cartilage degradation, subchondral bone loss, and a high risk of chronic joint damage or prosthetic failure.

Personalize your experience

Follow Pseudomonas aeruginosa joint infection and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it